MediaPress Releases Archives Media Inquiries In the News Press Releases FEATURED PRESS RELEASE November 9, 2026Adneuris Therapeutics Reaches Key Regulatory Milestone with FDA Submission of New Drug Application for Cebranopadol in Moderate-to-Severe Acute Pain October 14, 2026Tris Pharma Earns 2026 Great Place To Work Certification™ September 14, 2026Tris Pharma Introduces New 30-Count Bottle Size for QuilliChew ER® (methylphenidate HCl) Extended-Release Chewable Tablets for Attention Deficit Hyperactivity Disorder (ADHD) September 3, 2026Adneuris Therapeutics to Present at PAINWeek 2026 September 1, 2026Tris Pharma to Showcase ADHD Leadership and Commitment to Individualized Care at Fall 2026 Medical Conferences